Funding for this research was provided by:
Sanitätsrat Dr. Alexander Huebner und Gemahlin-Stiftung (NA)
fortüne grant (2412-0-0)
H2020 European Research Council (637752)
HMZ Private Foundation (NA)
fortüne grant (2485-0-0)
Received: 26 January 2018
Accepted: 17 October 2018
First Online: 14 November 2018
Ethics approval and consent to participate
: Ethical approval for using CD34<sup>+</sup> hematopoietic stem cells from healthy donors was obtained from Ethics commission, University Clinic of Tuebingen, Germany (829/2016BO2).
: Not applicable
: M.S.D.K. is listed as main inventor on a patent application related to Nuclease encoding modified mRNA. M.S.D.K. is a main inventor on a patent licensed to the biopharmaceutical company, Ethris GmbH. M.S.D.K., A.D., A.H., and J.S.A. are inventors (with M.S.D.K. as main inventor) on a patent application related to modified mRNA encoding hCFTR.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.